CIK: 0001737053
Total reported value
$38.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Apellis Pharmaceuticals, Inc | Stock-Other | 74.78% | +6.34% | -7.95% | |
| 2 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 12.33% | +3.03% | — | |
| 3 | MNLOUSD | Menlo Therapeutics INC | Stock-Other | 12.24% | -9.36% | — | |
| 4 | ✓ | Nabriva Therapeutics PLC | Stock-Other | 0.64% | — | -91.62% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Apellis Pharmaceuticals, Inc | +26% | -7.95% | Trim |
| 2 | VRNA | Verona Pharma PLC - Adr | +1.5% | — | Unchanged |
| 3 | ✓ | Nabriva Therapeutics PLC | -5.9% | -91.62% | Trim |
| 4 | MNLOUSD | Menlo Therapeutics INC | -21.6% | — | Unchanged |